Rohit Gundamaraju

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Cancer Stem Cells

Top Venues

International journal of molecular sciences

Disease markers

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Davide Barbagallo, Donatella Ponti, Barbara Bassani, Antonino Bruno, Laura Pulze, Shreya A Akkihal, Jonahunnatha Nesson George-William, Rohit Gundamaraju, Paola Campomenosi
MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces. International journal of molecular sciences 25 (15) (2024)
Davide Barbagallo, Donatella Ponti, Barbara Bassani, Antonino Bruno, Laura Pulze, Shreya A Akkihal, Jonahunnatha Nesson George-William, Rohit Gundamaraju, Paola Campomenosi
MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces. International journal of molecular sciences 25 (15) (2024)
Sayantanee Mukherjee, Rajib Dhar, Swathi Jonnalagadda, Sukhamoy Gorai, Sagnik Nag, Rishav Kar, Nobendu Mukherjee, Dattatreya Mukherjee, Rishabh Vatsa, Arikketh Devi, Krishnan Anand, Rohit Gundamaraju, Saurabh Kumar Jha, Athanasios Alexiou, Marios Papadakis
Exosomal miRNAs and breast cancer: A complex theranostics interlink with clinical significance. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2023)
Vemparthan Suvekbala, Haribaskar Ramachandran, Alaguraj Veluchamy, Mariano A Bruno Mascarenhas, Tharmarajan Ramprasath, M K C Nair, Venkata Naga Srikanth Garikipati, Rohit Gundamaraju, Ramasamy Subbiah
The Promising Epigenetic Regulators for Refractory Epilepsy: An Adventurous Road Ahead. Neuromolecular medicine (2022)
Rahul Bhattacharjee, Debanjan Das, Radheka Bhadhuri, Srija Chakraborty, Tanima Dey, Rupam Buragohain, Asim Nath, Kartik Muduli, Pranjan Barman, Rohit Gundamaraju
Cellular Landscaping of COVID-19 and Gynaecological Cancers: An Infrequent Correlation. Journal of oncology 2022 (2022)
Ankit Awasthi, Monica Gulati, Bimlesh Kumar, Jaskiran Kaur, Sukriti Vishwas, Rubiya Khursheed, Omji Porwal, Aftab Alam, Arya Kr, Leander Corrie, Rajan Kumar, Ankit Kumar, Monika Kaushik, Niraj Kumar Jha, Piyush Kumar Gupta, Dinesh Kumar Chellappan, Dinesh Kumar Chellappan, Kamal Dua, Saurabh Gupta, Rohit Gundamaraju, Pasupuleti Visweswara Rao, Dinesh Kumar Chellapan
Recent Progress in Development of Dressings Used for Diabetic Wounds with Special Emphasis on Scaffolds. BioMed research international 2022 (2022)
Indranil Chattopadhyay, Rohit Gundamaraju, Niraj Kumar Jha, Piyush Kumar Gupta, Abhijit Dey, Chandi C Mandal, Bridget M Ford
Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer? Disease markers 2022 (2022)
Vineeta Sharma, Sanat Kumar Dash, Kavitha Govarthanan, Rekha Gahtori, Nidhi Negi, Mahmood Barani, Richa Tomar, Sudip Chakraborty, Santosh Mathapati, Dillip Kumar Bishi, Poonam Negi, Kamal Dua, Dinesh Kumar Chellapan, Rohit Gundamaraju, Abhijit Dey, Janne Ruokolainen, Vijay Kumar Thakur, Kavindra Kumar Kesari, Niraj Kumar Jha, Piyush Kumar Gupta, Shreesh Kumar Ojha
Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction. Cells 10 (10) (2021)
Indranil Chattopadhyay, Rangarao Ambati, Rohit Gundamaraju
Exploring the Crosstalk between Inflammation and Epithelial-Mesenchymal Transition in Cancer. Mediators of inflammation 2021 (2021)
Piyush Kumar Gupta, Mrunmayee Saraff, Rekha Gahtori, Nidhi Negi, Surya Kant Tripathi, Jatin Kumar, Sanjay Kumar, Saad Hamad Aldhayan, Sugapriya Dhanasekaran, Mosleh Mohammad Abomughaid, Kamal Dua, Rohit Gundamaraju, Shreesh Kumar Ojha, Janne Ruokolainen, Niraj Kumar Jha, Kavindra Kumar Kesari
Phytomedicines Targeting Cancer Stem Cells: Therapeutic Opportunities and Prospects for Pharmaceutical Development. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)